If you’re feeling overwhelmed by depression, know that you’re not alone. In New York City, nearly 1 in 4 adults faces a mental health disorder each year. While doctors have prescribed selective serotonin reuptake inhibitors (SSRIs) for decades, ketamine offers renewed hope for patients who haven’t found relief yet. Explore each treatment’s unique healing potential and how you can rediscover a life worth living.
Ketamine and SSRIs both treat depression, but affect the brain in different ways. Understanding these differences can help you make an informed choice:
Unlike traditional antidepressants, SPRAVATO™ (esketamine) — the form of ketamine FDA-approved for psychiatry — primarily affects the glutamate system, a major communication network in the brain. SPRAVATO™ works by interacting with N-methyl-D-aspartate (NMDA) receptors. These receptors play a key role in how our brains learn and adapt, and SPRAVATO™ helps to stimulate them in a way that can improve mood.
Although research is still ongoing, pioneering studies suggest ketamine’s rapid antidepressant effects come from its ability to:
SSRIs primarily affect serotonin, a vital chemical messenger that regulates mood, sleep, appetite and many other functions. Although doctors often prescribe them for acute depression, SSRIs typically take several weeks of consistent use to produce noticeable effects, as the brain gradually adjusts.
SSRIs work by:
Consider the advantages and potential drawbacks of each medication to make an informed choice:
SSRIs like fluoxetine (Prozac), escitalopram (Lexapro) and Sertraline (Zoloft) offer several well-documented benefits, making them a frequently chosen initial treatment for depression:
Despite their benefits, it’s important to be aware of the potential drawbacks and limitations associated with SSRI treatment:
SPRAVATO™ (esketamine) offers a distinct set of advantages, particularly for individuals who haven’t experienced success with traditional antidepressants:
While SPRAVATO™ offers promising benefits, it’s important to be aware of a few factors:
Every person’s experience with depression is unique. To help you find the best path forward, these frequently asked questions about ketamine and SSRIs may be helpful:
The most effective choice depends on your individual needs and circumstances. SSRIs work well for many people, but they typically take time to reach their full effect. SPRAVATO™ (esketamine) can provide more rapid relief, sometimes within hours or days.
To find the best depression treatment, psychiatrists carefully consider your symptom severity, treatment history, specific symptoms and potential side effects. They’ll work with you to create a personalized plan and may suggest intensive outpatient programs (IOPs) for extra support. Open communication is key to finding the right path forward.
For a comprehensive, flexible ketamine solution, intensive outpatient treatment programs can provide scheduled therapy and support several times a week while allowing you to live at home. You’ll get access to frequent mental health check-ins and therapy, helping to reinforce your progress.
Research shows this can be a safe approach, but deciding whether to combine SPRAVATO™ with antidepressants is something you and your health care provider will discuss together. Being open and honest about all medications you’re taking, including over-the-counter drugs and supplements, is key to creating a treatment plan that works best for you.
There’s no one-size-fits-all solution for depression, and the most effective treatment plan is one that’s developed in partnership with a qualified mental health professional. Whether you’re considering ketamine, SSRIs, or a combination, working together with your doctor is essential. Together, you can explore different treatment options and find the approach that’s right for you.
Factors you and your physician will discuss during your consultation and evaluation include:
Proactively consulting with a qualified mental health professional is crucial for making informed and empowered treatment decisions. A skilled provider can offer personalized guidance, comprehensive support and evidence-based recommendations throughout your mental health journey.
SPRAVATO™ (esketamine) nasal spray is covered by most major insurance providers, making it an accessible option for many people seeking depression treatment. To confirm your coverage, contact your insurance company or speak with a knowledgeable health care provider.
Sessions are supervised in a comfortable, private setting. Most treatments are intravenous infusions lasting about an hour, with SPRAVATO™ nasal spray as a needle-free option. After a brief recovery, you’ll head home with a pre-arranged ride. Treatment typically includes six to 10 sessions over two to three weeks, with maintenance sessions as needed to support ongoing progress.
At Principium Psychiatry, we understand the unique challenges New Yorkers face when seeking mental health care. Led by Dr. Cohen and the team at Principium, we offer compassionate, evidence-based care, including innovative therapies like SPRAVATO™, ECT therapy and IOP.
Contact us online today or schedule a consultation and learn more about our personalized approach to lasting relief from depression.